Tavares, M.R.; Hrabánková, K.; Konefał, R.; Kaňa, M.; Říhová, B.; Etrych, T.; Šírová, M.; Chytil, P.
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy. Pharmaceutics 2021, 13, 179.
https://doi.org/10.3390/pharmaceutics13020179
AMA Style
Tavares MR, Hrabánková K, Konefał R, Kaňa M, Říhová B, Etrych T, Šírová M, Chytil P.
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy. Pharmaceutics. 2021; 13(2):179.
https://doi.org/10.3390/pharmaceutics13020179
Chicago/Turabian Style
Tavares, Marina R., Klára Hrabánková, Rafał Konefał, Martin Kaňa, Blanka Říhová, Tomáš Etrych, Milada Šírová, and Petr Chytil.
2021. "HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy" Pharmaceutics 13, no. 2: 179.
https://doi.org/10.3390/pharmaceutics13020179
APA Style
Tavares, M. R., Hrabánková, K., Konefał, R., Kaňa, M., Říhová, B., Etrych, T., Šírová, M., & Chytil, P.
(2021). HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy. Pharmaceutics, 13(2), 179.
https://doi.org/10.3390/pharmaceutics13020179